Aurinia Pharmaceuticals Inc.
AUPH
$15.43
$0.251.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 418.03% | 648.43% | 4,893.08% | 445.14% | 220.43% |
| Total Depreciation and Amortization | -0.49% | -0.23% | 0.02% | -0.44% | -2.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -858.31% | -1,220.18% | -1,280.31% | -46.52% | -28.03% |
| Change in Net Operating Assets | 88.60% | 137.90% | -261.22% | 200.17% | -8,325.77% |
| Cash from Operations | 89.08% | 159.65% | 205.62% | 320.15% | 5,488.60% |
| Capital Expenditure | 31.25% | 4.20% | 10.32% | -54.18% | 23.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.27% | -482.28% | -182.23% | 837.81% | 410.84% |
| Cash from Investing | -72.33% | -488.78% | -183.46% | 794.92% | 402.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.80% | -16.99% | -9.57% | 18.21% | 23.94% |
| Issuance of Common Stock | 372.82% | -51.12% | 61.23% | 43.20% | 19.52% |
| Repurchase of Common Stock | 8.28% | -21.77% | -132.72% | -387.12% | -356.65% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 48.74% | -32.48% | -116.15% | -302.45% | -282.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 547.26% | -1,391.01% | -109.32% | 489.49% | 140.57% |